179 related articles for article (PubMed ID: 29523890)
1. Pretransplant comprehensive geriatric assessment in hematopoietic cell transplantation: a single center experience.
Lin RJ; Shahrokni A; Dahi PB; Jakubowski AA; Devlin SM; Maloy MA; Robinson KS; Perales MA; Shah GL; Korc-Grodzicki B; Giralt SA
Bone Marrow Transplant; 2018 Sep; 53(9):1184-1187. PubMed ID: 29523890
[No Abstract] [Full Text] [Related]
2. Bone marrow transplantation. Preface.
Savani BN; Mohty M
Hematol Oncol Clin North Am; 2014 Dec; 28(6):xiii-xv. PubMed ID: 25459189
[No Abstract] [Full Text] [Related]
3. Immune reconstitution after autologous hematopoietic stem cell transplantation.
Porrata LF; Litzow MR; Markovic SN
Mayo Clin Proc; 2001 Apr; 76(4):407-12. PubMed ID: 11322356
[TBL] [Abstract][Full Text] [Related]
4. [Hematopoietic stem cell transplantation].
Sakamaki H
Nihon Rinsho; 2007 Jan; 65 Suppl 1():488-93. PubMed ID: 17474453
[No Abstract] [Full Text] [Related]
5. Delivering intensive therapies to older adults with hematologic malignancies: strategies to personalize care.
Olin RL
Hematology Am Soc Hematol Educ Program; 2019 Dec; 2019(1):63-70. PubMed ID: 31808886
[TBL] [Abstract][Full Text] [Related]
6. Is there an upper age limit for bone marrow transplantation?
Popplewell LL; Forman SJ
Bone Marrow Transplant; 2002 Feb; 29(4):277-84. PubMed ID: 11896423
[TBL] [Abstract][Full Text] [Related]
7. Cellular adoptive immunotherapy after autologous and allogeneic hematopoietic stem cell transplantation.
Porter DL; Hexner EO; Cooley S; Miller JS
Cancer Treat Res; 2009; 144():497-537. PubMed ID: 19779876
[No Abstract] [Full Text] [Related]
8. What the internist should know about stem cell transplant in the elderly patient.
Medinger M; Passweg J
Eur J Intern Med; 2018 Dec; 58():43-47. PubMed ID: 29960832
[TBL] [Abstract][Full Text] [Related]
9. Hematopoietic stem cell transplantation: the Vancouver experience.
Seftel MD; Barnett MJ
Hematology; 2002 Jun; 7(3):145-9. PubMed ID: 12243976
[TBL] [Abstract][Full Text] [Related]
10. Reduced-intensity allogeneic stem cell transplantation for patients whose prior autologous stem cell transplantation for hematologic malignancy failed.
Fung HC; Cohen S; Rodriguez R; Smith D; Krishnan A; Somlo G; Sahebi F; Senitzer D; O'Donnell MR; Stein A; Snyder DS; Spielberger R; Bhatia R; Falk P; Molina A; Nademanee A; Parker P; Kogut N; Popplewell L; Vora N; Margolin K; Forman SJ
Biol Blood Marrow Transplant; 2003 Oct; 9(10):649-56. PubMed ID: 14569561
[TBL] [Abstract][Full Text] [Related]
11. Combined use of autografting and non-myeloablative allografting for the treatment of hematologic malignancies and metastatic breast cancer.
Carella AM; Beltrami G; Lerma E; Cavaliere M; Corsetti MT
Cancer Treat Res; 2002; 110():101-12. PubMed ID: 11908194
[No Abstract] [Full Text] [Related]
12. Prognostic value of pretransplant serum C-reactive protein in patients receiving reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation.
Yamamoto W; Fujii E; Matsumoto K; Yamamoto E; Aoki J; Tanaka M; Ishigatsubo Y; Kanamori H
Int J Hematol; 2016 Apr; 103(4):444-52. PubMed ID: 26791379
[TBL] [Abstract][Full Text] [Related]
13. [Hematopoietic stem cell transplantation].
Yamane A; Okamoto S
Nihon Rinsho; 2012 Apr; 70 Suppl 2():226-9. PubMed ID: 23133958
[No Abstract] [Full Text] [Related]
14. The impact of diabetes mellitus and other comorbidities on hematopoietic stem cell collection and hematologic recovery post-transplantation.
Fiala MA; Slade M; Wang S; Park S; DiPersio J; Stockerl-Goldstein K
Leuk Lymphoma; 2017 Jan; 58(1):241-243. PubMed ID: 27243112
[No Abstract] [Full Text] [Related]
15. Comparison of two pretransplant predictive models and a flexible HCT-CI using different cut off points to determine low-, intermediate-, and high-risk groups: the flexible HCT-CI Is the best predictor of NRM and OS in a population of patients undergoing allo-RIC.
Barba P; Piñana JL; Martino R; Valcárcel D; Amorós A; Sureda A; Briones J; Delgado J; Brunet S; Sierra J
Biol Blood Marrow Transplant; 2010 Mar; 16(3):413-20. PubMed ID: 19922807
[TBL] [Abstract][Full Text] [Related]
16. Late effects after autologous hematopoietic cell transplantation.
Burns LJ
Biol Blood Marrow Transplant; 2009 Jan; 15(1 Suppl):21-4. PubMed ID: 19147072
[No Abstract] [Full Text] [Related]
17. [Autologous hematopoietic stem cell transplantation].
Imamura M
Nihon Rinsho; 2007 Jan; 65 Suppl 1():429-32. PubMed ID: 17474442
[No Abstract] [Full Text] [Related]
18. Hematopoietic Cell Transplant (HCT) in the Elderly: Myths, Controversies and Unknowns.
Al-Mansour Z; Ramanathan M; Cerny J
Drugs Aging; 2018 Dec; 35(12):1055-1064. PubMed ID: 30302674
[TBL] [Abstract][Full Text] [Related]
19. Allogeneic hematopoietic cell transplantation in patients ⩾70 years: which patients may benefit?
Haen SP; Pham M; Faul C; Dörfel D; Vogel W; Kanz L; Bethge WA
Blood Cancer J; 2016 Jul; 6(7):e443. PubMed ID: 27391575
[No Abstract] [Full Text] [Related]
20. Clinical Impact of Colonization with Multidrug-Resistant Organisms on Outcome after Autologous Stem Cell Transplantation: A Retrospective Single-Center Study.
Scheich S; Reinheimer C; Brandt C; Wichelhaus TA; Hogardt M; Kempf VAJ; Brunnberg U; Brandts C; Ballo O; von Metzler I; Kessel J; Serve H; Steffen B
Biol Blood Marrow Transplant; 2017 Sep; 23(9):1455-1462. PubMed ID: 28528711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
